Medical Updates & Immunization Site Training for All Healthcare Providers led by Pfizer Vaccines US Medical Affairs

Goal:  Educate providers and immunization staff personnel on the proper use of the Pfizer-BioNTech COVID-19 Vaccine

Session Topics Include:

• Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine for individuals 6 months through 4 years of age (DILUTE BEFORE USE/Maroon Cap)
• Now available: Gray Cap, Comirnaty®
• Use of each vaccine presentation, including storage, handling, preparation, and administration
• Question and answer session

Sessions will be updated to reflect the latest information.

Join the sessions at the designated times listed below:

Schedule through July 8, 2022*. Please check back for future training session information.

*Dates subject to change

Continuing medical education is NOT associated with this event

Emergency uses of the vaccine have not been approved or licensed by FDA, but have been authorized by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in individuals 5 years of age and older.  The emergency uses are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner. Please see EUA Fact Sheets at www.cvdvaccine-us.com.

Before administration of the vaccine, please see full Prescribing Information: 16+ years of age (DILUTE BEFORE USE/Purple Cap) and 16+ years of age (DO NOT DILUTE/Gray Cap) and EUA Fact Sheets for Vaccination Providers: 12+ years of age (DILUTE BEFORE USE/Purple Cap), 12+ years of age (DO NOT DILUTE/Gray Cap), 5 through 11 years of age (DILUTE BEFORE USE/Orange Cap) and 6 months through 4 years of age (DILUTE BEFORE USE/Maroon Cap). For the most recent prescribing information and fact sheets, please visit www.cvdvaccine-us.com.